CryoPort Inc (CYRX):企業の財務・戦略的SWOT分析

◆英語タイトル:CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2767
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:輸送・物流
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

CryoPort Inc (CYRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cryoport, Inc. (Cryoport) is a provider of cold chain logistics solutions for temperature-sensitive biological materials to the life science industries. It offers liquid nitrogen dry vapor shippers with advanced logistics management platform called Cryoportal, which provides credentials related to the shipment. It also offers SmartPak II condition monitoring system that provides information regarding the shipment including pressure, light, orientation, location, temperature, humidity and shock. Cryoport provides logistics consulting for supply chain optimization such as packaging and accessory design, lane validation, lane assessment, fleet management, laboratory relocation services, commercial launch preparation, clinical research expertise and training services. It offers services to therapy developers for personalized medicine, contract research organizations, cord blood repositories, vaccine manufacturers, bio-pharmaceutical institutions, contract manufacturers, diagnostic laboratories, clinical trial centers, academic and research institutions, in-vitro fertility (IVF) industry and animal husbandry related companies. Cryoport is headquartered in Irvine, California, the US.

CryoPort Inc Key Recent Developments

Jul 16,2018: Cryoport Partners with World Courier to Provide Best-In-Class Logistics Platform for Global Cell and Gene Therapy Market
May 03,2018: Cryoport Revenue Grows 48% for First Quarter; 62% in Biopharma
Mar 06,2018: Cryoport Reports 56% Revenue Growth for Fiscal Year Ended December 31, 2017
Feb 26,2018: McKesson Specialty Health and Cryoport Collaborate to Bolster Logistics Services to Support Commercialization of Cell and Gene Therapies
Feb 15,2018: Cryoport to Provide DiscGenics With Cutting Edge Cold Chain Logistics Support for its Phase I/II Trial

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
CryoPort Inc – Key Facts 6
CryoPort Inc – Key Employees 7
CryoPort Inc – Key Employee Biographies 8
CryoPort Inc – Major Products and Services 9
CryoPort Inc – History 10
CryoPort Inc – Company Statement 12
CryoPort Inc – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
CryoPort Inc – Business Description 16
Product Category: Animal Health 16
Performance 16
Product Category: Biopharmaceutical 16
Performance 16
Product Category: Reproductive Medicine 16
Performance 16
Geographical Segment: Americas 16
Performance 16
Geographical Segment: Asia Pacific (APAC) 17
Performance 17
Geographical Segment: Europe, Middle East and Africa (EMEA) 17
Performance 17
R&D Overview 17
CryoPort Inc – SWOT Analysis 18
SWOT Analysis – Overview 18
CryoPort Inc – Strengths 18
CryoPort Inc – Weaknesses 19
CryoPort Inc – Opportunities 20
CryoPort Inc – Threats 21
CryoPort Inc – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
CryoPort Inc, Recent Deals Summary 29
Section 4 – Company’s Recent Developments 30
Jul 16, 2018: Cryoport Partners with World Courier to Provide Best-In-Class Logistics Platform for Global Cell and Gene Therapy Market 30
May 03, 2018: Cryoport Revenue Grows 48% for First Quarter; 62% in Biopharma 31
Mar 06, 2018: Cryoport Reports 56% Revenue Growth for Fiscal Year Ended December 31, 2017 32
Feb 26, 2018: McKesson Specialty Health and Cryoport Collaborate to Bolster Logistics Services to Support Commercialization of Cell and Gene Therapies 34
Feb 15, 2018: Cryoport to Provide DiscGenics With Cutting Edge Cold Chain Logistics Support for its Phase I/II Trial 35
Nov 02, 2017: Cryoport Revenue Up 52%; Driven by BioPharma 36
Aug 08, 2017: Cryoport Revenue Up 52% for the Second Quarter of 2017, Driven by Biopharma 38
Jul 13, 2017: Cryoport Continues to Strengthen Sales Team with Appointments of Colin Coffua as Vice President, Strategic Accounts and John Phillips as Executive Director, Consulting Services 40
Jun 07, 2017: Cryoport Expands Agreement with Sanaria to Support Grant Awards with U.S. National Institutes of Health and U.S. Army 41
Mar 13, 2017: Cryoport Revenue Continues to Climb, Reporting 53% Growth for the Quarter Ended December 31, 2016 42
Section 5 – Appendix 44
Methodology 44
Ratio Definitions 44
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
CryoPort Inc, Key Facts 6
CryoPort Inc, Key Employees 7
CryoPort Inc, Key Employee Biographies 8
CryoPort Inc, Major Products and Services 9
CryoPort Inc, History 10
CryoPort Inc, Subsidiaries 14
CryoPort Inc, Key Competitors 22
CryoPort Inc, Ratios based on current share price 23
CryoPort Inc, Annual Ratios 24
CryoPort Inc, Annual Ratios (Cont...1) 25
CryoPort Inc, Interim Ratios 27
CryoPort Inc, Recent Deals Summary 29
Currency Codes 44
Capital Market Ratios 44
Equity Ratios 45
Profitability Ratios 45
Cost Ratios 46
Liquidity Ratios 46
Leverage Ratios 47
Efficiency Ratios 47

List of Figures
CryoPort Inc, Performance Chart (2013 - 2017) 26
CryoPort Inc, Ratio Charts 28

★海外企業調査レポート[CryoPort Inc (CYRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Direct Energy Marketing Ltd:電力:M&Aディール及び事業提携情報
    Summary Direct Energy Marketing Ltd (Direct Energy), a subsidiary of Centrica plc, is a provider of energy and energy-related services. The company supplies, transports, and distributes natural gas and electricity. Direct Energy also installs and maintains heating, ventilation and air conditioning ( …
  • Mohawk Industries, Inc.:企業の戦略・SWOT・財務分析
    Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Emlin Cosmetics:企業の戦略・SWOT・財務情報
    Emlin Cosmetics - Strategy, SWOT and Corporate Finance Report Summary Emlin Cosmetics - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Motiva Enterprises LLC:企業の戦略的SWOT分析
    Motiva Enterprises LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • MedMira Inc (MIR)-医療機器分野:企業M&A・提携分析
    Summary MedMira Inc (MedMira) is a medical device company that offers rapid diagnostics and technology solutions. The company offers products in areas of HIV, H. pylori, syphilis, multiplex, miriad rvf toolkit, and tissue and eye banks. It offers testing products for HIV, H. Pylori and syphilis, bes …
  • Kane Biotech Inc (KNE):企業の財務・戦略的SWOT分析
    Summary Kane Biotech Inc (Kane Biotech) is a biotechnology company which focuses on research, development and commercialization of novel products that prevent and remove biofilm related infections in humans and animals. The company’s products include StrixNB and Vetradent water additive, oral spray, …
  • SEAKR Engineering, Inc.:企業の戦略・SWOT・財務分析
    SEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report Summary SEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • UTC Engenharia SA:企業の戦略的SWOT分析
    UTC Engenharia SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Williams-Sonoma, Inc.:戦略・SWOT・企業財務分析
    Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report Summary Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Neurovance Inc-製薬・医療分野:企業M&A・提携分析
    Summary Neurovance Inc (Neurovance) is a clinical stage neuroscience focused company that develops centanafadine (CTN) SR for adult and pediatric Attention Deficit Hyperactivity Disorder (ADHD). CTN, formerly EB-1020, is a novel triple reuptake inhibitor that acts as a functional hybrid with activit …
  • Archroma Management LLC:企業の戦略的SWOT分析
    Archroma Management LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Air Liquide SA (AI):医療機器:M&Aディール及び事業提携情報
    Summary Air Liquide SA (Air Liquide) is a provider of gases, technologies and services for industrial and health care sectors. The company produces core air gases such as oxygen, nitrogen, and hydrogen along with argon and other rare gases. It supplies gases to customers in industries, including ste …
  • InVivo Therapeutics Corp:企業の製品パイプライン分析2018
    Summary InVivo Therapeutics Corp (InVivo), a subsidiary of InVivo Therapeutics Holdings Corp, is a medical device company that offers therapeutic products. The company develops and commercializes groundbreaking treatments for spinal cord injuries. Its products include biocompatible neuro spinal scaf …
  • SOGAZ Insurance Group:企業の戦略・SWOT・財務分析
    SOGAZ Insurance Group - Strategy, SWOT and Corporate Finance Report Summary SOGAZ Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • American Shared Hospital Services (AMS)-医療機器分野:企業M&A・提携分析
    Summary American Shared Hospital Services (ASHS) is a healthcare company that offers medical equipment to hospitals and medical centers. The company offers financial and healthcare tech solutions. Its financing solutions comprise feasibility studies and reimbursement analysis, facilities planning an …
  • PT Sun Life Financial Indonesia:企業の戦略・SWOT・財務情報
    PT Sun Life Financial Indonesia - Strategy, SWOT and Corporate Finance Report Summary PT Sun Life Financial Indonesia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Dunkin’ Brands Group Inc:企業の戦略・SWOT・財務情報
    Dunkin' Brands Group Inc - Strategy, SWOT and Corporate Finance Report Summary Dunkin' Brands Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sealed Air Corporation:企業の戦略・SWOT・財務情報
    Sealed Air Corporation - Strategy, SWOT and Corporate Finance Report Summary Sealed Air Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • TrialBee AB:製薬・医療:M&Aディール及び事業提携情報
    Summary TrialBee AB (TrialBee) is a provider of innovative software solutions that accelerates clinical trials. The company provides services such as online patient recruitment, online study feasibility, study retention and electronic data capture, among others. It offers cloud based solution which …
  • Amgen Inc (AMGN)-医療機器分野:企業M&A・提携分析
    Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncol …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆